Literature DB >> 3023669

Deletions in vaccine strains of pseudorabies virus and their effect on synthesis of glycoprotein gp63.

E A Petrovskis, J G Timmins, T M Gierman, L E Post.   

Abstract

The pseudorabies virus vaccine strains Norden and Bartha each have been reported to have deletions in the small unique component of the genome (B. Lomniczi, M. L. Blankenship, and T. Ben-Porat, J. Virol. 49:970-979, 1984). The deletion in Norden was shown to delete the entire coding region for gI but not any of the coding sequences for gp63. However, gp63 in Norden-infected cells was only 36 kilodaltons, and a 44-kilodalton form of gp63 was released into the medium. In Bartha, the deletion removed the coding region for all but 89 amino acids of gp63, and no gp63 was detected in either Bartha-infected cells or medium.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3023669      PMCID: PMC253379     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  16 in total

1.  Mapping of the structural gene of pseudorabies virus glycoprotein A and identification of two non-glycosylated precursor polypeptides.

Authors:  T C Mettenleiter; N Lukacs; H J Rziha
Journal:  J Virol       Date:  1985-01       Impact factor: 5.103

2.  Some characteristics of four attenuated vaccine virus strains and a virulent strain of Aujeszky's disease virus.

Authors:  J T van Oirschot; A L Gielkens
Journal:  Vet Q       Date:  1984-09       Impact factor: 3.320

3.  Genetic basis of the neurovirulence of pseudorabies virus.

Authors:  B Lomniczi; S Watanabe; T Ben-Porat; A S Kaplan
Journal:  J Virol       Date:  1984-10       Impact factor: 5.103

4.  Deletions in the genomes of pseudorabies virus vaccine strains and existence of four isomers of the genomes.

Authors:  B Lomniczi; M L Blankenship; T Ben-Porat
Journal:  J Virol       Date:  1984-03       Impact factor: 5.103

5.  Sequencing end-labeled DNA with base-specific chemical cleavages.

Authors:  A M Maxam; W Gilbert
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

6.  Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors.

Authors:  C Yanisch-Perron; J Vieira; J Messing
Journal:  Gene       Date:  1985       Impact factor: 3.688

7.  Presence of markers for virulence in the unique short region or repeat region or both of pseudorabies hybrid viruses.

Authors:  A Berns; A van den Ouweland; W Quint; J van Oirschot; A Gielkens
Journal:  J Virol       Date:  1985-01       Impact factor: 5.103

8.  Mapping and sequence of the gene for the pseudorabies virus glycoprotein which accumulates in the medium of infected cells.

Authors:  T J Rea; J G Timmins; G W Long; L E Post
Journal:  J Virol       Date:  1985-04       Impact factor: 5.103

9.  Use of lambda gt11 to isolate genes for two pseudorabies virus glycoproteins with homology to herpes simplex virus and varicella-zoster virus glycoproteins.

Authors:  E A Petrovskis; J G Timmins; L E Post
Journal:  J Virol       Date:  1986-10       Impact factor: 5.103

10.  Isolation, characterization, and physical mapping of a pseudorabies virus mutant containing antigenically altered gp50.

Authors:  M W Wathen; L M Wathen
Journal:  J Virol       Date:  1984-07       Impact factor: 5.103

View more
  54 in total

1.  Intravitreal injection of the attenuated pseudorabies virus PRV Bartha results in infection of the hamster suprachiasmatic nucleus only by retrograde transsynaptic transport via autonomic circuits.

Authors:  Gary E Pickard; Cynthia A Smeraski; Christine C Tomlinson; Bruce W Banfield; Jessica Kaufman; Christine L Wilcox; Lynn W Enquist; Patricia J Sollars
Journal:  J Neurosci       Date:  2002-04-01       Impact factor: 6.167

2.  Characterization of field isolates of suid herpesvirus 1 (Aujeszky's disease virus) as derivatives of attenuated vaccine strains.

Authors:  L S Christensen; I Medveczky; B S Strandbygaard; Z Pejsak
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

3.  Role of a structural glycoprotein of pseudorabies in virus virulence.

Authors:  T C Mettenleiter; L Zsak; A S Kaplan; T Ben-Porat; B Lomniczi
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

4.  Neuron-to-cell spread of pseudorabies virus in a compartmented neuronal culture system.

Authors:  T H Ch'ng; L W Enquist
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

5.  The gIII glycoprotein of pseudorabies virus is involved in two distinct steps of virus attachment.

Authors:  L Zsak; N Sugg; T Ben-Porat; A K Robbins; M E Whealy; L W Enquist
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

6.  UL54-null pseudorabies virus is attenuated in mice but productively infects cells in culture.

Authors:  Jennifer A Schwartz; Elizabeth E Brittle; Ashley E Reynolds; Lynn W Enquist; Saul J Silverstein
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

7.  Transcriptome signature of virulent and attenuated pseudorabies virus-infected rodent brain.

Authors:  Christina Paulus; Patricia J Sollars; Gary E Pickard; Lynn W Enquist
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

8.  Antigenic variation of pseudorabies virus glycoproteins g II and g III demonstrated by neutralizing monoclonal antibodies.

Authors:  S Yamada; T Imada; T Nishimori; K Sekikawa; M Shimizu
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

9.  Efficient incorporation of tegument proteins pUL46, pUL49, and pUS3 into pseudorabies virus particles depends on the presence of pUL21.

Authors:  Kathrin Michael; Barbara G Klupp; Axel Karger; Thomas C Mettenleiter
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

10.  Nucleotide sequence analysis of an infectious laryngotracheitis virus gene corresponding to the US3 of HSV-1 and a unique gene encoding a 67 kDa protein.

Authors:  K Kongsuwan; C T Prideaux; M A Johnson; M Sheppard; S Rhodes
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.